2009
DOI: 10.1213/ane.0b013e318187c4b1
|View full text |Cite
|
Sign up to set email alerts
|

Methemoglobinemia Related to Local Anesthetics: A Summary of 242 Episodes

Abstract: Benzocaine should no longer be used. Prilocaine should not be used in children younger than 6-mo-old, in pregnant women, or in patients taking other oxidizing drugs. The dose should be limited to 2.5 mg/kg.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
224
3
17

Year Published

2011
2011
2019
2019

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 263 publications
(247 citation statements)
references
References 19 publications
3
224
3
17
Order By: Relevance
“…25,26,37 The mechanism of anesthetic-induced methemoglobinemia is thought to occur as a result of direct oxidation of hemoglobin by amine metabolites derived from the amide-anesthetics. 37 Benzocaine use appears to have the highest incidence of methemoglobinemia. 37 However, many other drugs which possess oxidizing capacity can overwhelm the endogenous MetHb reductase and cause methemoglobinemia.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…25,26,37 The mechanism of anesthetic-induced methemoglobinemia is thought to occur as a result of direct oxidation of hemoglobin by amine metabolites derived from the amide-anesthetics. 37 Benzocaine use appears to have the highest incidence of methemoglobinemia. 37 However, many other drugs which possess oxidizing capacity can overwhelm the endogenous MetHb reductase and cause methemoglobinemia.…”
Section: Discussionmentioning
confidence: 99%
“…37 Benzocaine use appears to have the highest incidence of methemoglobinemia. 37 However, many other drugs which possess oxidizing capacity can overwhelm the endogenous MetHb reductase and cause methemoglobinemia. 25 In addition, direct exposure to inhaled NO can have significant impact on the systemic circulation and remote tissue perfusion via the action of stable NO metabolites.…”
Section: Discussionmentioning
confidence: 99%
“…Regardless of the cause or predisposing condition, the final pathway is similar: oxidation of deoxyhemoglobin, converting the ferrous (Fe 2+ ) ion in heme to the ferric (Fe 3+ ) valence. This oxidized species of hemoglobin is unable to bind to oxygen and instead binds to a molecule of water [1,2]. Normally, when oxygen binds to deoxyhemoglobin, an electron is shared between the iron in heme and the oxygen molecule, thus, the iron is reversibly oxidized.…”
Section: What Is the Pathophysiologic Basis For Methemoglobin Formation?mentioning
confidence: 99%
“…In RBCs, there are both major (95%) and minor (5%) pathways to reduce methemoglobin back to its oxygen-carrying state. Cytochrome-b 5 reductase (also known as NADH methemoglobin reductase) is the primary pathway involved in this reduction [1][2][3][4][5]. An additional enzyme, nicotinamide adenine dinucleotide phosphate (NADPH) methemoglobin reductase, is also capable of reducing methemoglobin; although its activity is quite limited during normal physiologic conditions, it becomes highly significant in the presence of methylene blue (see Fig.…”
Section: What Is the Pathophysiologic Basis For Methemoglobin Formation?mentioning
confidence: 99%
See 1 more Smart Citation